Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urine

Human papillomavirus (HPV) screening is crucial for early diagnosis and prevention of cervical cancer, yet fast and convenient HPV detection remains challenging, especially in resource-limited areas. Herein, we developed a nucleic acid test named SSMG-LAMP, which combined loop-mediated isothermal am...

Full description

Saved in:
Bibliographic Details
Main Authors: Duc Anh Thai, Jing Liu, Angel Gutierrez Ruiz, Yuqian Zhang, Marina Walther-Antonio, Yuguang Liu
Format: Article
Language:English
Published: Elsevier 2025-10-01
Series:Biosensors and Bioelectronics: X
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590137025000858
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849319587797008384
author Duc Anh Thai
Jing Liu
Angel Gutierrez Ruiz
Yuqian Zhang
Marina Walther-Antonio
Yuguang Liu
author_facet Duc Anh Thai
Jing Liu
Angel Gutierrez Ruiz
Yuqian Zhang
Marina Walther-Antonio
Yuguang Liu
author_sort Duc Anh Thai
collection DOAJ
description Human papillomavirus (HPV) screening is crucial for early diagnosis and prevention of cervical cancer, yet fast and convenient HPV detection remains challenging, especially in resource-limited areas. Herein, we developed a nucleic acid test named SSMG-LAMP, which combined loop-mediated isothermal amplification (LAMP) with an engineered DNA indicator (SYBR Safe – Malachite Green) for the point-of-care diagnosis of high-risk HPV strains (HPV 16 and 18) in urine. The assay can be completed within 45 min, including DNA extraction, SSMG-LAMP reaction, and signal readout using a simple, portable system. This system enabled the triple-mode detection of DNA targets using colorimetry, fluorometry, and electrochemistry, and can detect as low as 10 copies μL−1 HPV DNA. As a preliminary validation, we used SSMG-LAMP for a blind test of 16 clinical urine samples to detect HPV 16 and 18, and results showed a sensitivity of >80 % and specificity of up to 96.2 %, with a 95 % confidence interval. This triple-mode HPV detection strategy holds potential for point-of-care cervical cancer screening in low-resource settings.
format Article
id doaj-art-059270993b5341e58f494d5a2f1a6685
institution Kabale University
issn 2590-1370
language English
publishDate 2025-10-01
publisher Elsevier
record_format Article
series Biosensors and Bioelectronics: X
spelling doaj-art-059270993b5341e58f494d5a2f1a66852025-08-20T03:50:22ZengElsevierBiosensors and Bioelectronics: X2590-13702025-10-012610065810.1016/j.biosx.2025.100658Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urineDuc Anh Thai0Jing Liu1Angel Gutierrez Ruiz2Yuqian Zhang3Marina Walther-Antonio4Yuguang Liu5Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USADepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USADepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA; Department of Chemistry and Biochemistry, The University of Texas at El Paso, El Paso, TX, 79968, USADepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USAMicrobiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USA; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, 55905, USA; Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USADepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USA; Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA; Department of Immunology, Mayo Clinic, Rochester, MN, 55905, USA; Corresponding author. Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.Human papillomavirus (HPV) screening is crucial for early diagnosis and prevention of cervical cancer, yet fast and convenient HPV detection remains challenging, especially in resource-limited areas. Herein, we developed a nucleic acid test named SSMG-LAMP, which combined loop-mediated isothermal amplification (LAMP) with an engineered DNA indicator (SYBR Safe – Malachite Green) for the point-of-care diagnosis of high-risk HPV strains (HPV 16 and 18) in urine. The assay can be completed within 45 min, including DNA extraction, SSMG-LAMP reaction, and signal readout using a simple, portable system. This system enabled the triple-mode detection of DNA targets using colorimetry, fluorometry, and electrochemistry, and can detect as low as 10 copies μL−1 HPV DNA. As a preliminary validation, we used SSMG-LAMP for a blind test of 16 clinical urine samples to detect HPV 16 and 18, and results showed a sensitivity of >80 % and specificity of up to 96.2 %, with a 95 % confidence interval. This triple-mode HPV detection strategy holds potential for point-of-care cervical cancer screening in low-resource settings.http://www.sciencedirect.com/science/article/pii/S2590137025000858Human papillomavirusCervical cancerLoop-mediated isothermal amplificationPoint-of-careTriple-mode detection
spellingShingle Duc Anh Thai
Jing Liu
Angel Gutierrez Ruiz
Yuqian Zhang
Marina Walther-Antonio
Yuguang Liu
Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urine
Biosensors and Bioelectronics: X
Human papillomavirus
Cervical cancer
Loop-mediated isothermal amplification
Point-of-care
Triple-mode detection
title Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urine
title_full Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urine
title_fullStr Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urine
title_full_unstemmed Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urine
title_short Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urine
title_sort triple mode point of care diagnostics for high risk human papillomavirus in urine
topic Human papillomavirus
Cervical cancer
Loop-mediated isothermal amplification
Point-of-care
Triple-mode detection
url http://www.sciencedirect.com/science/article/pii/S2590137025000858
work_keys_str_mv AT ducanhthai triplemodepointofcarediagnosticsforhighriskhumanpapillomavirusinurine
AT jingliu triplemodepointofcarediagnosticsforhighriskhumanpapillomavirusinurine
AT angelgutierrezruiz triplemodepointofcarediagnosticsforhighriskhumanpapillomavirusinurine
AT yuqianzhang triplemodepointofcarediagnosticsforhighriskhumanpapillomavirusinurine
AT marinawaltherantonio triplemodepointofcarediagnosticsforhighriskhumanpapillomavirusinurine
AT yuguangliu triplemodepointofcarediagnosticsforhighriskhumanpapillomavirusinurine